ADC Therapeutics Statistics
Total Valuation
ADCT has a market cap or net worth of $139.21 million. The enterprise value is $331.93 million.
Important Dates
The last earnings date was Thursday, March 27, 2025, before market open.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ADCT has 99.08 million shares outstanding. The number of shares has increased by 18.91% in one year.
| Current Share Class | 99.08M |
| Shares Outstanding | 99.08M |
| Shares Change (YoY) | +18.91% |
| Shares Change (QoQ) | +0.55% |
| Owned by Insiders (%) | 6.43% |
| Owned by Institutions (%) | 29.81% |
| Float | 73.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.04 |
| Forward PS | 1.70 |
| PB Ratio | -0.69 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.82
| Current Ratio | 3.82 |
| Quick Ratio | 3.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -24.13% |
| Return on Invested Capital (ROIC) | -31.40% |
| Return on Capital Employed (ROCE) | -54.10% |
| Revenue Per Employee | $267,309 |
| Profits Per Employee | -$595,645 |
| Employee Count | 265 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 6.69 |
Taxes
In the past 12 months, ADCT has paid $166,000 in taxes.
| Income Tax | 166,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.60% in the last 52 weeks. The beta is 1.53, so ADCT's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | -68.60% |
| 50-Day Moving Average | 1.67 |
| 200-Day Moving Average | 2.53 |
| Relative Strength Index (RSI) | 36.19 |
| Average Volume (20 Days) | 345,024 |
Short Selling Information
The latest short interest is 4.56 million, so 4.61% of the outstanding shares have been sold short.
| Short Interest | 4.56M |
| Short Previous Month | 4.87M |
| Short % of Shares Out | 4.61% |
| Short % of Float | 6.25% |
| Short Ratio (days to cover) | 12.83 |
Income Statement
In the last 12 months, ADCT had revenue of $70.84 million and -$157.85 million in losses. Loss per share was -$1.62.
| Revenue | 70.84M |
| Gross Profit | -44.75M |
| Operating Income | -130.65M |
| Pretax Income | -170.29M |
| Net Income | -157.85M |
| EBITDA | -129.32M |
| EBIT | -130.65M |
| Loss Per Share | -$1.62 |
Full Income StatementBalance Sheet
The company has $250.87 million in cash and $443.09 million in debt, giving a net cash position of -$192.22 million or -$1.94 per share.
| Cash & Cash Equivalents | 250.87M |
| Total Debt | 443.09M |
| Net Cash | -192.22M |
| Net Cash Per Share | -$1.94 |
| Equity (Book Value) | -202.64M |
| Book Value Per Share | -2.05 |
| Working Capital | 226.92M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$123.84 million and capital expenditures -$867,000, giving a free cash flow of -$124.70 million.
| Operating Cash Flow | -123.84M |
| Capital Expenditures | -867,000 |
| Free Cash Flow | -124.70M |
| FCF Per Share | -$1.26 |
Full Cash Flow StatementMargins
Gross margin is -63.17%, with operating and profit margins of -184.44% and -222.83%.
| Gross Margin | -63.17% |
| Operating Margin | -184.44% |
| Pretax Margin | -222.60% |
| Profit Margin | -222.83% |
| EBITDA Margin | -182.56% |
| EBIT Margin | -184.44% |
| FCF Margin | n/a |
Dividends & Yields
ADCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.91% |
| Shareholder Yield | -18.91% |
| Earnings Yield | -112.98% |
| FCF Yield | -89.26% |
Analyst Forecast
The average price target for ADCT is $7.75, which is 451.60% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.75 |
| Price Target Difference | 451.60% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 35.22% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADCT has an Altman Z-Score of -6.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.42 |
| Piotroski F-Score | 3 |